Methionine-cycle gene guide
Official gene symbol: AHCY Common enzyme name and gene alias: SAHH

SAHH (AHCY) Gene and Methylation

Learn how the AHCY gene produces S-adenosylhomocysteine hydrolase, commonly called SAHH, and why clearing S-adenosylhomocysteine is important for continued methyl-transfer reactions.

A genetic methylation report may include a variant in AHCY. The meaning depends on the exact variant, genotype, evidence, and testing purpose—not simply the gene name, a red report label, or the presence of one altered allele.

SAHH and AHCY gene overview with methylation testing materials
AHCY helps clear SAH SAH is produced after SAM donates a methyl group. AHCY helps process SAH so it does not build up and interfere with methyltransferase reactions.
Official gene symbol AHCY The approved human gene symbol for adenosylhomocysteinase.
Common name SAHH Short for S-adenosylhomocysteine hydrolase.
Genomic location Chromosome 20q11.22 The report should also identify the exact tested variant.
Core reaction SAH ↔ Adenosine + Homocysteine The enzyme catalyzes a reversible reaction in the methionine cycle.
Direct answer

What Does the SAHH or AHCY Gene Do?

AHCY provides instructions for the SAHH enzyme, which catalyzes the reversible breakdown of S-adenosylhomocysteine into adenosine and homocysteine.

SAH is created after S-adenosylmethionine, or SAM, donates a methyl group. Because SAH can inhibit many SAM-dependent methyltransferases, processing it is important for maintaining the flow of methylation reactions. This does not mean that an AHCY genotype directly measures a person’s current methylation capacity.

Start with the correct terminology

AHCY Is the Gene; SAHH Is the Enzyme Name

Reports and educational articles may use several names for the same gene and protein. Knowing the distinction makes database searches and result interpretation more accurate.

AHCY

Official Human Gene Symbol

AHCY is the approved symbol used by NCBI, HGNC, ClinVar, genetic laboratories, and clinical databases.

SAHH

Common Enzyme Name

SAHH is short for S-adenosylhomocysteine hydrolase. It is also listed as an alias for AHCY.

AdoHcyase

Another Common Alias

Some scientific records use adenosylhomocysteinase or AdoHcyase. These terms should not be confused with AHCYL1 or AHCYL2.

Digital genetic report focused on AHCY, SAH clearance and the methionine cycle
AHCY acts after a methyl group has already been transferred. Its role is different from genes that produce SAM or remethylate homocysteine.
Why AHCY gets attention

SAH Clearance Helps Methylation Reactions Continue

AHCY is sometimes described as a methylation “gatekeeper” because it processes a by-product that can oppose methyltransferase activity.

  • SAM donates methyl groups: SAM is used by enzymes that transfer methyl groups to DNA, proteins, lipids, and other molecules.
  • SAH is produced afterward: Once SAM has donated its methyl group, it becomes S-adenosylhomocysteine.
  • SAH can inhibit methyltransferases: Removing SAH helps prevent product inhibition within the pathway.
  • AHCY processes SAH: The enzyme catalyzes its conversion to adenosine and homocysteine.
  • The wider pathway still matters: Homocysteine can be remethylated toward methionine or directed toward transsulfuration through other enzymes.

Review SNPs and methylation and genetic variants versus mutations before interpreting one highlighted AHCY result.

Simplified methyl-transfer cycle

Where AHCY Fits in Methylation

AHCY functions after SAM has donated a methyl group and before homocysteine continues into remethylation or transsulfuration.

STEP 01

Methionine

Methionine enters the cycle from dietary protein and the recycling of homocysteine.

STEP 02

SAM Production

Methionine adenosyltransferase enzymes convert methionine and ATP into SAM.

STEP 03

Methyl Transfer

SAM donates a methyl group through a methyltransferase reaction and becomes SAH.

STEP 04

AHCY Reaction

SAHH processes SAH into adenosine and homocysteine through a reversible reaction.

STEP 05

Pathway Continuation

Homocysteine can return toward methionine or enter the transsulfuration pathway.

Important: A cheek-swab genotype does not measure current SAM, SAH, adenosine, homocysteine, enzyme activity, or the intracellular SAM-to-SAH balance.
Why the reaction matters

Three Concepts Behind AHCY and Methylation

These concepts explain the biological relevance of AHCY without turning one consumer genetic result into a medical conclusion.

Methylation By-Product

SAH is created as a normal result of SAM-dependent methyltransferase reactions.

Feedback Inhibition

Higher intracellular SAH can oppose methyltransferase activity, making its removal relevant to pathway flow.

Connected Metabolism

The AHCY reaction links methyl transfer with adenosine, homocysteine, remethylation, and transsulfuration pathways.

Set realistic expectations

What an AHCY Genetic Report Can and Cannot Show

The report identifies inherited DNA at a tested location. It does not directly measure the current biochemical pathway.

A Report Can Help Show

  • Whether AHCY was included in the genetic panel
  • The exact variant or rsID that was analyzed
  • The genotype detected at that DNA location
  • Whether the result is heterozygous or homozygous
  • The provider’s educational variant explanation
  • How AHCY fits into SAM, SAH, and homocysteine metabolism

A Report Does Not Establish

  • Your current AHCY enzyme activity
  • Your current SAM or SAH concentration
  • Your current SAM-to-SAH ratio
  • Your current blood homocysteine or methionine level
  • The cause of muscle, neurological, or developmental symptoms
  • A diagnosis of SAHH deficiency
  • A personalized supplement, medication, or diet plan
Variant-specific interpretation

Do Not Interpret AHCY from the Gene Name Alone

Different AHCY variants can have very different classifications. Interpret the exact DNA change rather than a general “SAHH” label.

Check 01

Official Symbol

Search clinical databases using AHCY rather than relying only on the SAHH alias.

Check 02

Exact Variant

Record the rsID or HGVS notation, including the transcript version when it is available.

Check 03

Genotype and Inheritance

Confirm the alleles and zygosity. Clinical AHCY deficiency is generally associated with disease-causing variants in both copies.

Check 04

Evidence Status

Review classification, submitter, review status, functional evidence, population frequency, and evaluation date.

A wellness-panel label is not a clinical diagnosis. Terms such as “slow,” “reduced,” “risk,” or “impaired” may be proprietary interpretations. Check whether the exact AHCY variant has an established clinical classification before drawing a conclusion.

Keep two situations separate

A Wellness-Panel Finding Is Not the Same as AHCY Deficiency

Rare inherited SAHH deficiency involves a different level of evidence, testing, and medical follow-up from a common consumer-report variant.

Consumer Wellness Finding

This may be a common SNP included for educational pathway context. Its presence does not establish reduced enzyme activity or disease.

  • May cover only selected variants
  • Often uses cheek-swab or saliva collection
  • May provide proprietary wellness labels
  • Usually does not measure biochemical markers
  • Should not be used alone for medical decisions

Clinical AHCY Deficiency Evaluation

This rare metabolic condition requires clinical assessment, biochemical testing, and appropriate diagnostic genetic testing.

  • Associated with pathogenic AHCY variants
  • Generally follows an autosomal-recessive pattern
  • May involve elevated methionine, SAH, SAM, or CK
  • May involve muscle, neurological, or developmental findings
  • Requires metabolic or genetics specialist involvement
Why a broader panel may help

Read AHCY Beside the Rest of the Methionine Cycle

AHCY processes SAH, but other genes help produce SAM, remethylate homocysteine, and direct sulfur compounds through connected pathways.

Depending on the panel, related genes may include genes involved in methionine activation, folate-dependent remethylation, vitamin B12–dependent reactions, choline-related remethylation, and transsulfuration.

Broader coverage is most useful when the report identifies the exact variants, explains the strength of the evidence, and clearly states what the findings do not measure.

Broader methylation gene panel showing AHCY beside related methionine-cycle genes
AHCY is central to SAH processing, but one AHCY entry cannot represent current methylation status or the entire methionine cycle.
The practical US-local reality

Where to Take an AHCY Result for Appropriate Follow-Up

A consumer genetic report can be collected at home, but follow-up depends on the type of finding and the healthcare services available in your area.

For report-format questions, begin with the testing provider. A primary care clinician can assess symptoms and order conventional testing when appropriate. A genetic counselor can help review inheritance, family implications, and the quality of the variant evidence.

A rare pathogenic or likely pathogenic AHCY result, persistent hypermethioninemia, unusual muscle findings, developmental concerns, or an abnormal metabolic profile may require referral to a medical geneticist or biochemical genetics clinic. These services are often based at academic medical centers or children’s hospitals.

Smaller communities may not have a nearby metabolic genetics clinic. Ask whether a regional center offers an initial telehealth visit and confirm that the provider is licensed to see patients in your state.

Bring the entire report. A screenshot showing “SAHH slow” or a colored result is not enough to evaluate the variant, laboratory method, panel limitations, or clinical classification.

EEAT and evidence

Verify SAHH Claims Using the Official AHCY Record

Reliable interpretation should use the official gene symbol, exact variant, current clinical classification, review status, population frequency, functional evidence, inheritance pattern, and biochemical context.

Evidence reviewed: July 20, 2026.
NCBI gene annotations and ClinVar classifications can change as new research and laboratory submissions become available.
Medical disclaimer: This page provides general genetic and wellness education. It does not interpret your personal result, diagnose SAHH deficiency, or replace clinical care. Do not change medication, supplements, protein intake, methionine intake, or medical treatment based only on a consumer AHCY result.
Common questions

SAHH and AHCY Gene FAQs

Direct answers about the official gene name, SAH processing, methylation, homocysteine, rare AHCY deficiency, and responsible result interpretation.

Is SAHH the official gene symbol?

No. The official human gene symbol is AHCY. SAHH is a common abbreviation for S-adenosylhomocysteine hydrolase and is also listed as an AHCY alias.

What does the AHCY gene do?

AHCY provides instructions for the enzyme that catalyzes the reversible breakdown of S-adenosylhomocysteine into adenosine and homocysteine.

Why is SAH important in methylation?

SAH is produced after SAM donates a methyl group. SAH can inhibit SAM-dependent methyltransferases, so its processing is relevant to the continued flow of methyl-transfer reactions.

Can an AHCY genetic report measure my SAH level?

No. A genetic report identifies inherited DNA at selected locations. It does not directly measure current SAH, SAM, adenosine, methionine, homocysteine, or enzyme activity.

Does an AHCY variant diagnose impaired methylation?

No. A variant must be interpreted using its exact identity, genotype, classification, evidence, inheritance pattern, and clinical context. One variant does not measure whole-body methylation.

Is SAHH deficiency inherited?

The rare clinical disorder caused by pathogenic AHCY variants is generally inherited in an autosomal-recessive pattern, meaning disease usually involves clinically significant variants in both gene copies.

Does one heterozygous AHCY result mean I have SAHH deficiency?

Not by itself. The exact variant and its classification matter, and a single heterozygous result is not automatically diagnostic of an autosomal-recessive condition.

Can AHCY deficiency cause high methionine?

Rare pathogenic AHCY variants can cause a metabolic condition associated with hypermethioninemia and abnormal methionine-cycle metabolites. Diagnosis requires appropriate biochemical and clinical genetic testing.

Should I change supplements because of an AHCY result?

Do not change supplements based only on a consumer genetic result. Decisions should consider the exact variant, current health, diet, medications, laboratory findings, and professional guidance.

Who can help interpret a potentially important AHCY result?

A genetic counselor can review variant evidence and inheritance. A medical geneticist or biochemical genetics specialist may be appropriate when a rare pathogenic result or abnormal metabolic findings are present.

Make the next step evidence-based

Review the Exact AHCY Variant Before Acting on an SAHH Result

Confirm the official gene symbol, exact variant, genotype, clinical classification, evidence, panel coverage, and report limitations before deciding whether the finding is relevant.

Educational genetic information should support better questions—not replace biochemical testing, clinical genetics, or individual medical care.